Bookmark and Share

Faculty Publications

  • Karen E.Anderson KE, Weiner WJ, Lang AE (Editors): Behavioral Neurology Of Movement Disorders (Advances in Neurology), second edition (Hardcover) by Lippincott, Williams and Wilkins, Philadelphia, 2005.
  • Anderson KE, Lynch K, Zarahn E, Scarmeas N, Van Heertum R, Sackeim H, Moeller JR, Stern Y: Related Articles, Links H215O PET study of impairment of nonverbal recognition with normal aging. J Neuropsychiatry Clin Neurosci. 2005 Spring;17(2):192-200.
  • Anderson KE. Huntington's disease and related disorders. Psychiatr Clin North Am. 2005 Mar;28(1):275-90, x. Review.
  • Stern Y, Habeck C, Moeller J, Scarmeas N, Anderson KE, Hilton HJ, Flynn J, Sackeim H, van Heertum R. Related Articles, Links Brain networks associated with cognitive reserve in healthy young and old adults. Cereb Cortex. 2005 Apr;15(4):394-402.
  • Scarmeas N, Habeck C, Anderson KE, Hilton J, Devanand DP, Pelton GH, Tabert MH, Flynn J, Park A, Ciappa A, Tycko B, Stern Y. Related Articles, Links Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele). Am J Geriatr Psychiatry. 2004 Nov-Dec;12(6):596-605.
  • Anthony, B. J, Anthony L. G., Morrel T. and Acosta, M. (2005). Evidence for social and behavior problems in low-Income, urban preschoolers: effects of site, classroom and teacher. Journal of Youth and Adolescence, 34, 31-39.
  • Anthony, B., Anthony L. G., Morrel T. and Acosta, M. (2005). Evidence for Social and Behavior Problems in Low-Income, Urban Preschoolers: Effects of Site, Classroom and Teacher. Journal of Youth and Adolescence, 34, 31-39.
  • Anthony, L.G., Anthony, B.J., Glanville, D.N., Naiman, D.Q., Waanders, C.W., & Shaffer, S. (2005). The relationships between parenting stress, parenting behavior and preschoolers’ social competence and behavior problems in the classroom. Infant and Child Development, 14, 133-154.
  • Anthony, L..G., Anthony, B., Glanville, D., Naiman, D., Waanders, C and Shaffer, S. (2005). The relationships between parenting stress, parenting behavior and preschoolers’ social competence and behavior problems in the classroom. Infant and Child Development, Special Issue on Parenting Stress. 14, 133-154.
  • Drake, R.E., & Bellack, A.S. (2005). Psychiatric rehabilitation. In B.J.Sadock & V.A. Sadock (Eds.). Kaplan & Sadock’s Comprehensive Textbook of Psychiatry. Baltimore: Lippincott, Williams & Wilkins.
  • Bellack, A.S., Schooler, N.R., Marder, S.R., Kane, J.M., Brown, C.H., & Yang, Y. (2004). Do clozapine and risperidone affect social competence and problem solving? American Journal of Psychiatry, 161, 364-367.
  • Blanchard, J.J., Sayers, S.L., Collins, L.M., & Bellack, A.S. (2004). Affectivity in the problem-solving interactions of schizophrenia patients and their family members. Schizophrenia Research. 69(1):105-17.
  • Bellack, A.S. & Tenhula, W.N. (2005). Behavioral Approaches to Schizophrenia. In M. Hersen & J. Rosqvist (Eds.), Encyclopedia of Behavior Modification and Cognitive Behavior Therapy, Volume I: Adult Clinical Applications. Sage Publications.
  • Bellack, A.S., Dickinson, D., Morris, S.E., & Tenhula, W.N. (2005). The development of a computer-assisted cognitive remediation program for patients with schizophrenia. Israel Journal of Psychiatry and Related Sciences, 42 (1): 5-14.
  • Boyd SJ, Tashkin DP, Huestis M, Heishman SJ, Dermand JC, Simmons MS, & Gorelick DA: Strategies for quitting among non-treatment-seeking marijuana smokers. American Journal on Addictions 14:35-42, 2005.
  • Gorelick, David A.; Kim, Yu Keong; Bencherif, Badreddine; Boyd, Susan J; Nelson, Richard; Copersino, Marc, Endres, Christopher J, Dannals, Robert F; Frost, J.James: Imaging Brain Mu-Opioid Receptors in Abstinent Cocaine Users: Time Course and Relation to Cocaine Craving. Biological Psychiatry, 57:1573-1582, 2005.
  • Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT Jr. Olanzapine treatment of residual positive and negative symptoms. American Journal of Psychiatry 162:124-129, 2005.
  • Buchanan RW, Davis M, Goff D, Green MF, Keefe RSE, Leon AC, Nuechterlein KH, Laughren T, Levin R, Stover E, Fenton W, Marder SR. A summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia, Schizophrenia Bulletin 31(1):5-19, 2005.
  • Giuliani NR, Calhoun VD, Pearlson GD, Francis A, Buchanan RW. Voxel-based morphometry versus region of interest: A comparison of two methods for analyzing gray matter differences in schizophrenia. Schizophrenia Research 74(2-3):135-147, 2005.
  • Hong LE, Summerfelt A, McMahon R, Adami H, Francis G, Elliott A, Buchanan RW, Thaker GK. Evoked gamma band synchronization and the liability for schizophrenia. Schizophrenia Research 70(2-3):293-302, 2004.
  • Messias E, Kirkpatrick B, Bromet E, Ross D, Buchanan RW, Carpenter WT Jr, Tek C, Kendler KS, Walsh D, Dollfus S. Summer birth and deficit schizophrenia: A pooled analysis from 6 countries. Archives of General Psychiatry 61:985-989, 2004.
  • Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophrenia Research 70(2-3):175-186, 2004.
  • Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell N, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT Jr, Friedman A, Kleinberg D, Yevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. American Journal of Psychiatry 161(8):1334-1349, 2004.
  • Buchanan RW, Pearlson G. Prefrontal cortex, structural analysis: Segmenting the prefrontal cortex. American Journal of Psychiatry 161(11):1978, 2004.
  • Buchanan RW, Carpenter WT Jr. Concept of schizophrenia: In: Sadock BJ, Sadock VA (eds), Kaplan & Sadock's Comprehensive Textbook of Psychiatry /VI, Eighth Edition. New York: Lippincott Williams & Wilkins, 2005, pp 1329-1345.
  • Andreasen NC, Carpenter Jr. WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: Proposed criteria and rationale for consensus. American Journal of Psychiatry, 162:441-449, 2005.
  • Prentice KJ, Gold JM, Carpenter Jr. WT. Optimistic bias in the perception of personal risk: Patterns in schizophrenia. American Journal of Psychiatry, 162:507-512, 2005.
  • Kelly DL, Carpenter WT, Conley RR. First Episode Schizophrenia: A Focus on Pharmacologic Treatment and Safety Considerations. Drugs, 65(8):1113-38, 2005.
  • Carpenter WT, Thaker GK. 7 Schizophrenia. 13 Psychiatry. ACP Medicine Online. Dale DC, Federman DD, Eds. WebMD Inc., New York, 2004. http://acpmedicine.com. June, 2004.
  • Sullivan K, Rappeport J, Carpenter WT, Adelman RM, Phillips RTM, Better H, Kane R, Pitrof L, Mackowiak PA. Was Joan of Arc criminally responsible for her alleged acts of heresy? The Pharos, Summer 2004.
  • Carpenter Jr. WT. Clinical constructs and therapeutic discovery. Schizophrenia Research, 72(1):69-73, 2004.
  • Kelly DL, Carpenter WT, Conley RR. First Episode Schizophrenia: A Focus on Pharmacologic Treatment and Safety Considerations. Drugs, 65(8):1113-38, 2005.
  • Roberts, R.C., J.K. Roche and R.R. Conley Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis. Synapse, 56:185-197, 2005.
  • Dwivedi Y, H.S. Rizavi, P.K. Shukla, J. Lyons, G. Faludi, M. Palkovits, A. Sarosi, R.R. Conley, R.C. Roberts, C.A. Tamminga, and G.N. Pandey Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol. Psychiatry, 55:234-243, 2004.
  • Conley RR, Kelly DL, Beason Held LL, Holcomb HH, Richardson CM. The effects of clozapine and high dose olanzapine on brain function in treatment resistant schizophrenia: a case study. J Psychopharmacology 18(3): 429 31, 2004.
  • Bellack, A.S., Dickinson, D., Morris, S.E., & Tenhula, W.N. (2005). The development of a computer-assisted cognitive remediation program for patients with schizophrenia. Israel Journal of Psychiatry and Related Sciences, 42 (1): 5-14.
  • Dickinson, D., Iannone, V.N., Wilk, C., & Gold, J.M. (2004). General and Specific Cognitive Deficits in Schizophrenia. Biological Psychiatry, 55, 826-833.
  • Arnold, D.S., Rosse, R.B., Dickinson, D., Benham, R., Deutsch, S.I., & Nelson, M.W. (2004). Adjuvant Therapeutic Effects of Galantamine on Apathy in a Schizophrenia Patient. Journal of Clinical Psychiatry, 65, 1723-24.
  • Dickerson F, Brown C, Kreyenbuhl J, Goldberg R, Fang LJ, Dixon L: Sexual and Reproductive Behaviors Among Persons with Serious Mental Illness, Psychiatric Services, 2004, 55:1299-301.
  • Dixon L and Goldman H. Forty Years of Progress in Community Mental Health: The Role of Evidence-Based Practices. Administration and Policy in Mental Health 31 (5): 381-392, 2004 [Reprinted from the Australia and New Zealand Journal of Psychiatry.]
  • Dixon L, Kreyenbuhl J, Dickerson F, Donner T, Brown C, Wohlheiter K, Postrado L, Goldberg R, Messias E, Fang LJ: A Comparison of Type 2 Diabetes Outcomes Among Individuals With and Without Severe Mental Illnesses, Psychiatric Services 2004, 55: 892-900.
  • Dixon, L., Lucksted, A., Stewart, B., Burland, J., Brown, C.H., Postrado, L., McGuire, C., Hoffman, M. (2004). Outcomes of the Peer-taught 12-week Family to Family Education Program for Serious Mental Illnesses. Acta Psychiactrica Scandinavica, 109:207-215, 2004.
  • Murray-Swank, A. Dixon, L. Family psychoeducation as an evidence-based practice. CNS Spectrums, 2004, 9: 905-912.
  • Murray-Swank, A. & Dixon, L. (2005). Evidence-based practices for working with families of individuals with serious mental illness. Chapter in Evidence-based Mental Health Practice: A Textbook, Ed by Robert Drake, Matt Merrens, David Lynde. New York: W.W. Norton.
  • Resnick S, Rosenheck R, Dixon L, Lehman A: Correlates of Family Contact with the Mental Health System: Allocation of a Scarce Resource, Mental Health Services Research, 2005 Jun;7(2):113-21.
  • Koenig, J,I, Elmer, G.I., Shepard, P., Lee, P., Mayo, C., Joy, B., Hercher, E., Brady, D. Stress during gestation produces alterations in adult rat behavior: Relevance to schizophrenia. Behavioral Brain Research, 156(2):251-261, 2005.
  • Kafkafi N., Benjamini Y, Elmer, G.I. Golani I., Genotype x Environment interactions: A way out of the problem. Proceeding National Academy of Sciences 102(12):4619-24, 2005.
  • Kafkafi, N. and Elmer, G.I. Activity density in the open field: a measure for differentiating the effect of psychostimulants within and across mouse genotypes. Pharmacology, Biochemistry and Behavior 80(2):239-49, 2005.
  • Elmer, G.I., Sydnor, J., Guard, H., Hercher, E., Vogel, M.W. Neurodevelopmental model of altered sensory gating in rats treated prenatally with the antimitotic AraC. Psychopharmacology, 170:108-14, 2004.
  • Lipkind D., Sakov A., Kafkafi N., Elmer G.I, Benjamini Y. and Golani I. New replicable anxiety related measures of wall versus center behavior of mice in the open field. Journal of Applied Physiology, 97:347-359, 2004.
  • Fuller, Rebecca L.; Luck, Steven J.; McMahon, Robert P.; Gold, James M., Working Memory Consolidation Is Abnormally Slow in Schizophrenia. Journal of Abnormal Psychology. May Vol 114(2) 279-290, 2005.
  • Gold JM, Green MF. Schizophrenia: cognition. In: Sadock BJ, Sadock VA (eds), Kaplan & Sadock's Comprehensive Textbook of Psychiatry /VI, Eighth Edition, Volume I , New York: Lippincott Williams & Wilkins, 2005, pp 1426-1448.
  • Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT Jr. Olanzapine treatment of residual positive and negative symptoms. American Journal of Psychiatry; 162(1):124-129, 2005.
  • Prentice KP, Gold JM, Carpenter WTC Jr. Optimistic bias in the perception of personal risk: patterns in schizophrenia. American Journal of Psychiatry; 162(3):507-512, 2005.
  • Fuller RL, Luck SJ, McMahon RP, Gold JM. Working memory consolidation is abnormally slow in schizophrenia. Journal of Abnormal Psychology; 114(2):279-290, 2005.
  • Wilk CM, Gold JM, Humber K, Dickerson F, Fenton WS, Buchanan RW. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status. Schizophrenia Research; 70:175-186, 2004.
  • Green MF, Nuechterlein KH, Gold JM, Barch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RSE, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biological Psychiatry; 56:301-307, 2004.
  • Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophrenia Research; 72:21-28, 2004.
  • Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research; 72:29-39, 2004.
  • Goldberg, R.W. (2004). Hepatitis and HIV screening, education and treatment for adults with serious mental illness. General Hospital Psychiatry. 26 (2) 167-168.
  • Goldberg, R.W., Rollins, A.L., and McNary, S.W. (2004). The working alliance inventory: Modification and use with seriously mentally ill consumers in a vocational rehabilitation program. Psychiatric Rehabilitation Journal. 27 (3) 267-270.
  • Goldman HH. “Vooruitstrevend GGZ-beleid in conservatieve tijden,” Maandblad Geestelijke volksgezondheit 59(5): 417-427, 2004. [“Making Progress in Mental health policy in conservative times” Paper written following the Arie Querido lecture, translated from Dutch.].
  • Goldman HH, Hammersley D. “A tribute to John A. Talbott, M.D. (Taking Issue). Psychiatric Services 55(10):1089, 2004.
  • Goldman HH. Editor’s introduction: “Do you walk to school; or do you carry your lunch?” Psychiatric Services 56(4):419, 2005.
  • Corrigan PW, Lurie BD, Goldman HH, Skopen N, Medasani K, Phelan S. “How adolescents perceive the stigma of mental illness and alcohol abuse,” Psychiatric Services 56(5):544-550, 2005.
  • Cromwell J, Maier J, Gage B, Drozd E, Osber D, Richter E, Greenwald L, Goldman H. “Characteristics of high staff intensive Medicare psychiatric inpatients.” Health Care Financing Review 26(1): 103-117. Fall 2004.
  • Cromwell J, Drodz E, Gage B, Maier J, Richter E, Goldman HH. “Variation in patient routine costliness in US psychiatric facilities,” J of MH Policy and Economics 8(1):15-28, March 2005.
  • Himelhoch S, Kreyenbuhl J, Lehman AL, Dixon L: Prevalence of Chronic ObstructivePulmonary Disease Among Individuals with Serious Mental Illness, American Journal of Psychiatry, 2004, 161(12):2317-9.
  • Himelhoch, S., Treisman, G., Moore, R. Gebo, KA. Does Presence of a Psychiatric Disorder in AIDS Patients Affect the Initiation of Antiretroviral Treatment and Duration of Therapy? J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1457-1463.
  • Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA. Clozapine but not Haloperidol Re-Establishes Normal Task-Activated rCBF Patterns in Schizophrenia within the Anterior Cingulate cortex. Neuropsychopharmacology 29:171-178, 2004.
  • Holcomb HH, Parwani A, McMahon R, Lahti AC, Medoff DR, Tamminga CA. Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research 127 (3): 207-217, 2004.
  • Conley RR, Kelly DL, Beason Held LL, Holcomb HH, Richardson CM. The effects of clozapine and high dose olanzapine on brain function in treatment resistant schizophrenia: a case study. J Psychopharmacology 18(3): 429 31, 2004.
  • Lahti AC, Holcomb HH, Weiler MA, Medoff Dr, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29 (1): 171-8, 2004.
  • Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first and second generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res. 139(1): 19-30, 2005.
  • Hong LE, Tagamets M, Avila MT, Wonodi I, Holcomb H, Thaker GK. Evidence of specific motion processing pathway deficit during pursuit eye movement in schizophrenia: a performance matched fMRI study. Biological Psychiatry 57(7): 726-32, 2005.
  • Holcomb HH, Rowland LM, Tagamets MA. Cognitive dysfunction in schizophrenia: glutamatergic hypoactivity and dopaminergic failure. Drug Discovery Today: Disease Mechanisms 1(4): 435-439, 2004.
  • Tamminga CA, Holcomb HH. Phenotype of schizophrenia: a review and formulation. Mol Psychiatry 10 (1): 27-39, 2005.
  • Hong LE, Avila MT, Wonodi I, McMahon RP, Thaker GK: Reliability of a portable head-mounted eye tracking instrument for schizophrenia research. Behavior Research Methods, 37: 133-138, 2005.
  • Hong LE, Wonodi I, Avila MT, Buchanan RW, McMahon RP, Mitchell BD, Stine OC, Carpenter Jr. WT, Thaker GK. Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 136:8-11, 2005.
  • Hong LE, Avila MT, Thaker GK. Response to unexpected target changes during sustained visual tracking in schizophrenic patients. Exp Brain Res., 165:125-131,2005.
  • Hong LE, Tagamets M, Avila MT, Wonodi I, Holcomb H, Thaker GK: Evidence of specific motion processing pathway deficit during pursuit eye movement in schizophrenia: a performance-matched fMRI study. Biol Psychiatry. 57:726-32, 2005.
  • Hong LE, Tagamets M, Avila MT, Wonodi I, Holcomb H, Thaker GK: Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched fMRI study. Biol Psychiatry, 57:726-32, 2005.
  • Hong LE, Summerfelt A, McMahon RP, Thaker GK, Buchanan RW. Gamma / beta oscillation and sensory gating deficit in schizophrenia. NeuroReport,15:155-164, 2004.
  • Hong LE, Summerfelt A, McMahon RP, Adami H, Francis G, Elliott A, Buchanan RW, Thaker GK. Evoked Gamma Band Synchronization and the Liability for Schizophrenia. Schizophr Res.,70:293-302, 2004.
  • Jaffe, J.H., Jaffe, A.B. Neurobiology of Opioids. In: Galanter, M., Kleber, H.D., eds. The American Psychiatric Press Textbook of Substance Abuse Treatment, Third Edition, pp. 17-30. Washington, D.C: American Psychiatric Press, 2004.
  • Jaffe, J.H., Anthony, J.C. Substance-Related Disorders: Introduction and Overview. In: Sadock, B.J., Sadock, V.A., eds., Kaplan & Sadocks Comprehensive Textbook of Psychiatry, 8th Edition, pp. 1137-1167. Baltimore: Lippincott Williams & Wilkins, 2005.
  • Jaffe, J.H., Ling W. Rawson, R.A.. Amphetamine (or Amphetamine-like)-Related Disorders. In: Sadock, B.J., Sadock, V.A., eds., Kaplan & Sadocks Comprehensive Textbook of Psychiatry, 8th Edition, pp. 1188-1200. Baltimore: Lippincott Williams & Wilkins, 2005.
  • Jaffe, J.H., Rawson, R.A., Ling, W. Cocaine-Related Disorders. In: Sadock, B.J., Sadock, V.A., eds., Kaplan & Sadocks Comprehensive Textbook of Psychiatry, 8th Edition, pp.1220-1237. Baltimore: Lippincott Williams & Wilkins, 2005.
  • Jaffe, J.H., Strain EC. Opioid-related disorders. In: Sadock, B.J., Sadock, V.A., eds., Kaplan & Sadocks Comprehensive Textbook of Psychiatry, 8th Edition, pp.1265-1290. Baltimore: Lippincott Williams & Wilkins, 2005.
  • Knapp, C.M., Ciraulo, D.A., Jaffe J. Opiates: Clinical aspects. In: Lowinson, J.H., Ruiz, P., Millman R.B., Langrod, J. G., eds., Substance Abuse: A Comprehensive Textbook, 4th Edition. Baltimore: Lippincott Williams & Wilkins, 2005, pp. 180-195.
  • Jaffe, J.H.: Learning from uncommon events: Comment on Degenhardt et al., 2005. Addiction 100: 921-922, 2005.
  • Epstein, S. Renner J.A., Ciraulo, D.A., Knapp, C.M., Jaffe, J.H. Opioids. In, Kranzler H.R., Ciraulo, D.A., eds.: Clinical Manual of Addiction Psychopharmacology. Washington, DC, American Psychiatric Publishing, Inc., 2005, pp. 55-110.
  • Kelly DL, Carpenter WT, Conley RR. First Episode Schizophrenia: A Focus on Pharmacologic Treatment and Safety Considerations. Drugs, 65(8):1113-38, 2005.
  • Kelly DL, Love RC, Mackowick M, McMahon RP, Conley RR, Atypical antipsychotic use in a state-hospital inpatient adolescent population. J Child Adolesc Psychopharmacol, 14:75-85, 2004.
  • Conley RR, Kelly DL, Beason Held LL, Holcomb HH, Richardson CM. The effects of clozapine and high dose olanzapine on brain function in treatment resistant schizophrenia: a case study. J Psychopharmacology 18(3): 429 31, 2004.
  • Buchanan RW, Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT Jr. Olanzapine treatment of residual positive and negative symptoms. American Journal of Psychiatry 162:124-9, 2005.
  • Messias E, Kirkpatrick B, Bromet E, Ross D, Buchanan RW, Carpenter WT Jr., Tek C, Kendler KS, Walsh D. Summer birth and deficit schizophrenia: A pooled analysis from six countries. Archives of General Psychiatry 61:985-989, 2004.
  • Galderisi S, Maj M, Kirkpatrick B, Piccardi P, Mucci A, Invernizzi G, Rossi A, Pini S, Vita A, Cassano P, Stratta P, Severino G, Del Zompo M. COMT Val158Met and BDNF C270T polymorphisms in schizophrenia: a case-control study. Schizophrenia Research 73:27-30, 2005.
  • Roberts RC, Xu L, Roche JK, Kirkpatrick B. The ultrastructural localization of reelin in the cortex in postmortem human brain. Journal of Comparative Neurology 482:294-308, 2005.
  • Kiser LJ, Black MA. (2005). Family processes in the midst of urban poverty. Aggression and Violent Behavior, 10(6):715-750.
  • Kiser LJ, Bennett L, Heston JD, Paavola M. (2005). Family ritual and routine: Comparing clinical and non-clinical families. Journal of Child and Family Studies, 14(3):357-372.
  • Koenig JI, Cho JY Expression of kainic acid-preferring glutatmate receptor subunit mRNA in the paraventricular nucleus: modulation by stress and glucocorticoid hormones. J. Neuroendocrinology, 17:111-118, 2005.
  • Lee PR, Brady DL, Shapiro R, Dorsa DA, Koenig JI. Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology, 2005 (published online 2/16/05 - http://www.acnp.org/citations/NPP021605040391/default.pdf).
  • Koenig JI, Carpenter WT. Cannabis and psychosis. Br. J. Psychiatry 185:352, 2004.
  • Sharifi JL, Koenig JI. Regulators of G-protein signaling (RGS) mRNA expression in nucleus accumbens is controlled by estrogen and drugs of abuse. Neuroreport 15:2433-2436, 2004.
  • Sarpal D, Koenig JI, Brady D, Clerkin L, Shepard PD. Distribution of SK3 mRNA-containing neurons in the rat ventral midbrain and their relationship to dopamine cells. Synapse 53:104-113, 2004.
  • Amico JA, Vollmer RR, Karam JR, Lee PR, Li X, Koenig JI, McCarthy MM. Centrally administered oxytocin elicits exaggerated grooming in oxytocin null mice. Pharmacol. Biochem. Behav. 78:333-339, 2004.
  • Koenig JI, Elmer GI, Shepard P, Lee P, Joy B, Hersher E, Mayo C, Brady D. Behavioral, neurochemical and neuroendocrinological effects of prenatal stress in rats: potential relevance to schizophrenia. Behav. Brain Res. 156:251-261, 2005.
  • Carpenter WT, Koenig JI, Bilbe G, Bischoff S. A model for academic/industry collaboration. Schizophrenia Bulletin; 30:997-1004, 2004.
  • Carpenter, Jr., WT, Koenig JI. Molecular medicine and the prospects for prevention and early intervention in schizophrenia. In: Stone WS, Faraone SV, Tsuang MT, eds. Early Clinical Intervention and Prevention in Schizophrenia. Humana Press Inc., Totowa, NJ; 355-366, 2004.
  • Erdely, H.A., A.C. Lahti, M.B. Lopez, C.S. Myers, R.C. Roberts , C.A. Tamminga , and M.W. Vogel Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci., 19:3125-3128, 2004.
  • Lahti AC, Holcomb HH, Weiler MA, Medoff Dr, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29 (1): 171-8, 2004.
  • Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Res. 2005 May 30;139(1): 19-30.
  • Frank RG, Berndt ER, Busch AB, Lehman AF: Quality-constant price indexes for the ongoing treatment of schizophrenia: An exploratory study. Special Issue of the Quarterly Review of Economics and Finance, National Bureau of Economic Research, Inc., 22:390-409, 2004.
  • Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J: Practice Guideline for the Treatment of Patients with Schizophrenia, 2nd Edition. American Journal of Psychiatry, Supplement, 161(2):1-56, Supplement, 2004.
  • Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, et al: The schizophrenia patient outcomes research team (PORT): Updated treatment recommendations 2003, Schizophrenia Bulletin, 30(2):193-217, 2004.
  • Busch A, Frank RG, Lehman AF: The effect of a managed behavioral health care carve-out on quality of care for medicaid patients diagnosed with schizophrenia. Archives of General Psychiatry, 61:442-448, 2004.
  • Resnick SG, Rosenheck RA & Lehman AF: An exploratory analysis of correlates of recovery. Psychiatric Services, 55:540-547, 2004.
  • Lehman AF, Goldman HH, Dixon LB, Churchill R: Evidence-based mental health treatments and services: Examples to inform public policy. Milbank Memorial Fund, 1-32, 2004.
  • Mohr PE, Cheng CM, Claxton K, Conley RR, Feldman Jacob JJ, Hargreaves WA, Lehman AF, et al: The Heterogeneity of Schizophrenia in Disease States. Schizophrenia Research, Nov 1;71(1):83-95, 2004.
  • Resnick, SG, Fontana, A, Lehman, AF, & Rosenheck, RA. An empirical conceptualization of the recovery orientation. Schizophrenia Research, 75:119-128, 2005.
  • Resnick SG, Rosenheck RA, Dixon L, Lehman AF. Correlates of family contact with the mental health system: Allocation of a scarce resource. Mental Health Services Research, 7(2):113-121, 2005.
  • Resnick SG, Fontana A, Lehman AF, Rosenheck RA. An empirical conceptualization of the recovery orientation. Schizophrenia Research, 2005, 75:119-128.
  • Cook JA, Lehman AF, Drake R, McFarlane WR, et al: Integration of psychiatric and vocational Services: A multisite randomized, controlled trial of supported employment. American Journal of Psychiatry, 162:1948-1956, 2005.
  • Razzano LA, Cook JA, Burke-Miller JK, Mueser KT, Pickett-Schenk SA, Grey DD, Goldberg RW, Blyler CR, Gold PB, Leff HS, Lehman AF, et al: Clinical Factors Associated with Employment Among People with Severe Mental Illness: Findings from the Employment Intervention Demonstration Program. Journal of Nervous and Mental Disease, 2005, 193:705-713.
  • Lever, N., Stephan, S., & Axelrod, J., & Weist, M. D. (2004). Accessing fee for service revenue in school mental health: A partnership with an outpatient mental health center. Journal of School Health, 74. 91-94.
  • Lever, N., Anthony, L., Stephan, S., Moore, E., Harrison, B., & Weist, M.D. (in press). Best practice in expanded school mental health. In C. Franklin & M. Harris (Eds.), School Social Work Training and Resource Manual. New York: Oxford University Press.
  • Nelson, P., Lever, N., Stephan, S., & Weist, M.D. (October 2004). Mental health in schools – past, present and future: Reflections from two national centers. Paper presented at the 9th Annual Conference on Advancing School-Based Mental Health, Dallas, TX.
  • Lucksted, A., McGuire, C., Postrado, L., Kreyenbuhl, J., & Dixon, L. Specifying Cigarette Smoking & Quitting among People with Serious Mental Illness. American Journal of Addictions, 13(2):128-138, 2004.
  • Lucksted, A., Lesbian, Gay, Bisexual, and Transgender People Receiving Services in the Public Mental Health System: Raising Issues, Journal of Gay and Lesbian Psychotherapy, 8(3/4), 2004. [Also re-published as a chapter in the Handbook of LGBT Issues in Community Mental Health, Binghamton, NY: Haworth Medical Press, 2004.]
  • Ritsher, J.E.B., Lucksted, A., Otilingam, P.G., & Grajales, M. Hearing Voices: Explanations and Implications, Psychiatric Rehabilitation, 27(3):219-227, 2004.
  • Luber, MP: Psychoanalysis and the academic world (Reporter, Panel, 43rd Congress of the Int. Psychoanal. Assoc.), Int J Psychoanal 2005:86:521-3.
  • Buchanan RW., Ball MP, Weiner E, Kirkpatrick B, Gold JM, McMahon RP, Carpenter WT Jr. Olanzapine treatment of residual positive and negative symptoms. American Journal of Psychiatry, 162(1):124-129, 2005.
  • Fuller, Rebecca L.; Luck, Steven J.; McMahon, Robert P.; Gold, James M., Working Memory Consolidation Is Abnormally Slow in Schizophrenia. Journal of Abnormal Psychology. May Vol 114(2) 279-290, 2005.
  • Hong LE, Avila MT, Wonodi I, McMahon RP, Thaker GK: Reliability of a portable head-mounted eye tracking instrument for schizophrenia research. Behavior Research Methods, 37: 133-138, 2005.
  • Hong LE, Summerfelt A, McMahon R, Adami H, Francis G, Elliott A, Buchanan RW, Thaker GK. Evoked gamma band synchronization and the liability for schizophrenia. Schizophrenia Research 70(2-3):293-302, 2004.
  • Kelly DL, Love RC, Mackowick M, McMahon RP, Conley RR, Atypical antipsychotic use in a state-hospital inpatient adolescent population. J Child Adolesc Psychopharmacol, 14:75-85, 2004.
  • Bellack, A.S., Dickinson, D., Morris, S.E., & Tenhula, W.N. (2005). The development of a computer-assisted cognitive remediation program for patients with schizophrenia. Israel Journal of Psychiatry and Related Sciences, 42 (1): 5-14.
  • Primm AB, Osher FC, and Gomez MB: Race and Ethnicity, Mental Health Services and Cultural Competence in the Criminal Justice System: Are We Ready to Change?, Community Mental Health Journal, Vol. 41 (5), 557-569, 2005.
  • Sacks S, Osher FC, Klitzner M, and Urban R: The Substance Abuse and Mental Health Services Administrations – Co-occurring Center for Excellence, Journal of Dual Diagnosis, Vol. 1, (2):107-112, 2005.
  • Steadman HJ, Scott JE, Osher FC, Agnese TK, and Robbins PC: Validating the Brief Jail Mental Health Screen, Psychiatric Services, 7 (56), 816 – 822, 2005.
  • Prentice KJ, Gold JM, Carpenter Jr. WT. Optimistic bias in the perception of personal risk: Patterns in schizophrenia. American Journal of Psychiatry, 162:507-512, 2005.
  • Carpenter LL, Moreno FA, Kling MA, Anderson GM, Regenold WT, Labiner DM, Price LH (2004) Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 56: 418-26.
  • Kozlovsky N, Regenold WT, Levine J, Rapoport A, Belmaker RH, Agam G (2004) GSK-3beta in cerebrospinal fluid of schizophrenia patients. J Neural Transm 111: 1093-8.
  • Regenold WT, Hisley KC, Obuchowski A, Lefkowitz DM, Marano C, Hauser P (2005) Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. J Affect Disord 85: 341-50.
  • Regenold WT, Phatak P, Kling MA, Hauser P (2004) Post-mortem evidence from human brain tissue of disturbed glucose metabolism in mood and psychotic disorders. Mol Psychiatry 9: 731-3.
  • Roberts, R.C., J.K. Roche and R.R. Conley Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis. Synapse, 56:185-197, 2005.
  • Hutcherson, L. and R.C. Roberts: The immunocytochemical localization of substance P in the human striatum: a postmortem ultrastructural study. Synapse, 57:191-201, 2005.
  • Erdely, H.A., R.A. Lahti, M.B. Lopez, C.S. Myers, R.C. Roberts, C.A. Tamminga , and M.W. Vogel Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci., 19:3125-3128., 2004.
  • Dwivedi Y, H.S. Rizavi, P.K. Shukla, J. Lyons, G. Faludi, M. Palkovits, A. Sarosi, R.R. Conley, R.C. Roberts, C.A. Tamminga, and G.N. Pandey Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol. Psychiatry, 55:234-243, 2004.
  • Kelley, J.J. and R.C. Roberts: Effects of haloperidol on cholinergic striatal interneurons: relationship to oral dyskinesias. J. Neural Transm., 111:1075-1091, 2004.
  • Roberts, R.C., L. Xu, J.K. Roche, and B. Kirkpatrick: The ultrastructural localization of reelin in the cortex in postmortem human brain. J. Comp. Neurol., 482:294-308, 2004.
  • Pesold, C., R.C. Roberts and B. Kirkpatrick (2004) Neuroscience of Schizophrenia. In: Textbook of Biological Psychiatry, J. Panksepp (ed.), Wiley-Liss, 9:267-298.
  • Roberts, R.C. and C. Tamminga, The neuropathology of schizophrenia. In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, B.J. Sadock and V.A. Sadock (eds.), Lippincott Williams & Wilkins, 2004.
  • A. Rassoulpour, H.-Q. Wu, E. X. Albuquerque and R. Schwarcz: Prolonged nicotine administration results in bi-phasic, brain-specific changes in kynurenate levels in the rat. Neuropsychopharmacology, 30, 697-704, 2005.
  • A. Rassoulpour, H.-Q. Wu, S. Ferre and R. Schwarcz: Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum. J. Neurochem., 93, 762-765, 2005.
  • P. Samadi, L. Gregoire, A. Rassoulpour, P. Guidetti, E. Izzo, R. Schwarcz and P. Bédard: Effect of kynurenine 3-hydroxylase inhibition on the dyskinetic and anti-parkinsonian response to L-Dopa in parkinsonian monkeys. Movement Dis., 20, 792-802, 2005.
  • H.-Q. Wu, A. Rassoulpour, J. H. Goodman, H. E. Scharfman, E. H. Bertram and R. Schwarcz: Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats. Epilepsia, 46, 1010-1016, 2005.
  • P. Guidetti, R. E. Luthi-Carter, S. J. Augood and R. Schwarcz: Neostriatal and cortical quinolinate levels are increased in early grade Huntington’s Disease. Neurobiol. Dis., 17, 455-461, 2004.
  • Koenig JI, Elmer GI, Shepard PD, Lee PR, Mayo C, Joy B, Hercher E and Brady DL Prenatal exposure to a repeated variable stress paradigm elicits behavioral and neuroendocrinological changes in the adult offspring: potential relevance to schizophrenia. Behavioral Brain Research 156:251-261, 2005.
  • Kiss C, Shepard P, Bari F and Schwarcz R Cortical spreading depression augments kynurenate levels and reduces malonate toxicity in the rat cortex. Brain Research 1002:129-135, 2004.
  • Canavier CC, Perla SR and Shepard PD Scaling of prediction error does not confirm chaotic dynamics underlying irregular firing using interspike intervals from midbrain dopamine neurons. Neuroscience 129:491-502, 2004.
  • Sarpal D, Koenig JI, Adelman JP, Brady D, Clerkin L and Shepard PD Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53:104-113, 2004.
  • Joy B, McMahon RP and Shepard PD Effects of acute and chronic clozapine on D-amphetamine-induced disruption of auditory gating in the rat. Psychopharmacology 174:274-282, 2004.
  • Salkever DS, Slade EP, Karakus M, Russo P, and Palmer L. Estimation of Antipsychotic Effects on Hospitalization Risk in a Naturalistic Study with Selection on Unobservables. Journal of Nervous and Mental Disease, 192(2): 119-128, 2004.
  • Slade EP, and Wissow LS, Spanking in Early Childhood and Later Behavior Problems: A Prospective Study of Infants and Young Toddlers, Pediatrics, 113(5): 1321-1330, 2004.
  • Slade EP, Racial/Ethnic Disparities in Parent Perception of Child Need for Mental Health Care Following School Disciplinary Events, Mental Health Services Research, 6(2): 75-92, 2004.
  • Stephan, S., Weist, M.D., Anthony, L., Lever, N., Moore, E., & Harrison, B. (March 2005). School mental health quality in action. Poster presented at the 18th Annual Conference, A System of Care for Children’s Mental Health: Expanding the Research Base, Tampa, FL.
  • Talbott, J.A., (2004): The future of psychiatric services: is there any? Psychiatrist Administrator 4: 5-12.
  • Talbott, J.A. (2005): La réalité des mesures de protection concernant la situation des malades mentaux aux Etats-Unis. English : The rights and protection of mental patients in the USA. Info Psychiatrique 81 :1-4
  • Talbott, J.A. (2005): Professionalism in the Health Sciences: Lessons Learned from its Definition, Evaluation and Teaching in a Medical School. Journal of Veterinary Education 32:237-241.
  • Talbott, J.A., (2005): L’avenir de la psychiatrie; en réponse à Apollon, Bergeron et Cantin. Santé mentale au Québec 30 :29-34. English : The future of psychiatry : a response to Apollon, Bergeron et Cantin.
  • Talbott, J.A., (2006): The chronic psychiatric patient: problems, promises and perspectives, past, present and future. Acta Psychiatrica Scandinavica 113: Supplement 429: 101-108.
  • Talbott, J.A. (Editor-in-Chief): Ballenger, J.C., Frances, R.J., Jensen, P.S., Markowitz, J.C., Meltzer, H.Y., and Simpson, G.M.(Editors) (2004): The Year Book of Psychiatry and Applied Mental Health. Year Book Medical Publishers, Inc. Chicago.
  • Talbott, J.A. (Editor-in-Chief): Ballenger, J.C., Buckley, P.F., Frances, R.J., Jensen, P.S., and Markowitz, J.C. (Editors) (2005): The Year Book of Psychiatry and Applied Mental Health. Year Book Medical Publishers, Inc. Chicago.
  • Talbott, J.A. (2004): Community Psychiatry. In Talbott, J.A. (Editor-in-Chief): Ballenger, J.C., Frances, R.J., Jensen, P.S., Markowitz, J.C., Meltzer, H.Y., and Simpson, G.M. (Editors) (2004): The Year Book of Psychiatry and Applied Mental Health. Year Book Medical Publishers, Inc. Chicago.
  • Talbott, J.A. (2005): Community Psychiatry. In Talbott, J.A. (Editor-in-Chief): Ballenger, J.C., Buckley, P.F., Frances, R.J., Jensen, P.S., and Markowitz, J.C. (Editors) (2005): The Year Book of Psychiatry and Applied Mental Health. Year Book Medical Publishers, Inc. Chicago.
  • Dickerson, F.D., Tenhula, W.N., & Green-Paden, L. (2005). The token economy for schizophrenia: Review of the literature and recommendations for future research. Schizophrenia Research. 75 (2-3): 405-416.
  • Bellack, A.S. & Tenhula, W.N. (2005). Behavioral Approaches to Schizophrenia. In M. Hersen & J. Rosqvist (Eds.), Encyclopedia of Behavior Modification and Cognitive Behavior Therapy, Volume I: Adult Clinical Applications. Sage Publications.
  • Bellack, A.S., Dickinson, D., Morris, S.E., & Tenhula, W.N. (2005). The development of a computer-assisted cognitive remediation program for patients with schizophrenia. Israel Journal of Psychiatry and Related Sciences, 42 (1): 5-14.
  • Hong LE, Avila MT, Wonodi I, McMahon RP, Thaker GK: Reliability of a portable head-mounted eye tracking instrument for schizophrenia research. Behavior Research Methods, 37: 133-138, 2005.
  • Hong LE, Wonodi I, Avila MT, Buchanan RW, McMahon RP, Mitchell BD, Stine OC, Carpenter Jr. WT, Thaker GK. Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 136:8-11, 2005.
  • Hong LE, Avila MT, Thaker GK. Response to unexpected target changes during sustained visual tracking in schizophrenic patients. Exp Brain Res., 165:125-131,2005.
  • Hong LE, Tagamets M, Avila MT, Wonodi I, Holcomb H, Thaker GK: Evidence of specific motion processing pathway deficit during pursuit eye movement in schizophrenia: a performance-matched fMRI study. Biol Psychiatry. 57:726-32, 2005.
  • Hong LE, Tagamets M, Avila MT, Wonodi I, Holcomb H, Thaker GK: Specific motion processing pathway deficit during eye tracking in schizophrenia: a performance-matched fMRI study. Biol Psychiatry, 57:726-32, 2005.
  • Wonodi I, Hong LE, Avila MT, Buchanan RW, Carpenter WT Jr., Stine OC, Mitchell BD & Thaker GK. Association between Polymorphism of the SNAP29 Gene Promoter Region and Schizophrenia. Schizophr Res, 78:339-341,2005.
  • Hong LE, Summerfelt A, McMahon RP, Thaker GK, Buchanan RW. Gamma / beta oscillation and sensory gating deficit in schizophrenia. NeuroReport,15:155-164, 2004.
  • Hong LE, Summerfelt A, McMahon RP, Adami H, Francis G, Elliott A, Buchanan RW, Thaker GK. Evoked Gamma Band Synchronization and the Liability for Schizophrenia. Schizophr Res.,70:293-302, 2004.
  • Myers CS, Robles OA, Kakoyannis N, Sherr JD, Avila MT, Blaxton TA, Thaker GK: Nicotine improves long-term memory in schizophrenic patients. Psychopharmacology 174:334-340, 2004.
  • Thaker GK, Wonodi I, Avila MT, Hong LE, Stine OC. Catechol-O-Methyltransferase polymorphism and eye tracking in schizophrenia: a preliminary report. Am J Psychiatry, 161:2320-2, 2004.
  • Tonelli LH, Gunsolly CA, Belyaskaya E, Atwood RA, Sternberg EM. Increased pro-thyrotropin –releasing hormone transcription in hypophysiotropic neurons of Lewis rats. Journal of Neuroimmunology. 153:143-149, 2004.
  • Elmer, G.I., Sydnor, J., Guard, H., Hercher, E., Vogel, M.W. Neurodevelopmental model of altered sensory gating in rats treated prenatally with the antimitotic AraC. Psychopharmacology, 170:108-14, 2004.
  • Erdely, H.A., R.A. Lahti, M.B. Lopez, C.S. Myers, R.C. Roberts , C.A. Tamminga , and M.W. Vogel Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci., 19:3125-3128, 2004.
  • Katz EC, King SD, Schwartz RP, Weintraub E, Barksdale W, Robinson R & Brown BS, Cognitive ability as a factor in engagement in drug abuse treatment. American Journal Drug Alcohol Abuse, 31(3):359-69, 2005.
  • Katz EC, Brown BS, Schwartz RP, Weintraub E, Barksdale W, Robinson R. Role induction: a method for enhancing early retention in otpatient drug-free treatment. Journal Consult Clinical Psychology, 72(2):227-34, 2004.
  • Welsh, C. & Doniger, J. “Commentary on The Corner” Academic Medicine; 79(12), 2004.The Corner; photograph published in Academic Medicine; 79(12), 2004.
  • Wonodi I, Stine OC, Mitchell BD, Buchanan RW, Thaker GK: Association between Val Wonodi I, Hong LE, Avila MT, Buchanan RW, Carpenter WT Jr., Stine OC, Mitchell BD & Thaker GK. Association between Polymorphism of the SNAP29 Gene Promoter Region and Schizophrenia. Schizophr Res, 78:339-341,2005.
  • Wonodi I, Adami HM, Sherr J, Avila MT, Hong LE, Thaker GK. Naltrexone treatment of tardive dyskinesia in patients with schizophrenia. J Clin Psychopharmacol, 24:441-5,2004.
  • Wonodi, I, Adami HM, Cassady SL, Sherr JD, Avila MT, Thaker GK Ethnicity and the course of Tardive Dyskinesia in outpatients presenting to the Motor Disorders Clinic at the Maryland Psychiatric Research Center. Journal of Clinical Psychopharmacology. 24: 592-598, 2004.
  • Nelson, P., Lever, N., Stephan, S., & Weist, M.D. (October 2004). Mental health in schools – past, present and future: Reflections from two national centers. Paper presented at the 9th Annual Conference on Advancing School-Based Mental Health, Dallas, TX.
  • Paternite, C., Weist, M.D., Flaspohler, P., & Adelsheim, S. (March 2005). School mental health topical discussion. Paper presented at the 18th Annual Conference, A System of Care for Children’s Mental Health: Expanding the Research Base, Tampa, FL.
  • Weist, M.D., Stephan, S.H., & Lever, N. (2004). The future of expanded school mental health (communication). Journal of School Health, 74, 191.